Investigate Natural Product Indolmycin and the Synthetically Improved Analogue Toward Antimycobacter

Yang, Yuhong; Xu, Yuanyuan; Yue, Yuan; Wang, Heng; Cui, Yumeng; Pan, Miaomiao; Zhang, Xi; Zhang, Lin; Li, Haitao; Xu, Min; Tang, Yefeng; Chen, Shawn

doi:10.1021/acschembio.1c00394

Investigate Natural Product Indolmycin and the Synthetically Improved Analogue Toward Antimycobacter

Journal Article · 01 January 2022 · ACS Chem. Biol.

DOI:https://doi.org/10.1021/acschembio.1c00394· OSTI ID:1845517

Yang, Yuhong; Xu, Yuanyuan; Yue, Yuan; Wang, Heng; Cui, Yumeng; Pan, Miaomiao; Zhang, Xi; Zhang, Lin; Li, Haitao; Xu, Min; Tang, Yefeng; Chen, Shawn

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; FOREIGN

OSTI ID:: 1845517

Journal Information:: ACS Chem. Biol., Vol. 17, Issue (1)

Country of Publication:: United States

Language:: ENGLISH

References (65)

Mycobacterium tuberculosis No authors listed Trends in Microbiology https://doi.org/10.1016/j.tim.2018.02.012		June 2018
Ecology and evolution of Mycobacterium tuberculosis No authors listed Nature Reviews Microbiology https://doi.org/10.1038/nrmicro.2018.8		February 2018
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus No authors listed Journal of Clinical Medicine https://doi.org/10.3390/jcm9082541		August 2020
Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus No authors listed Nature Reviews Microbiology https://doi.org/10.1038/s41579-020-0331-1		February 2020
To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis? No authors listed Current Opinion in Microbiology https://doi.org/10.1016/j.mib.2009.11.006		February 2010
Selman A. Waksman, Winner of the 1952 Nobel Prize for Physiology or Medicine No authors listed Applied and Environmental Microbiology https://doi.org/10.1128/aem.01143-13		January 2014
Genome mining for the search and discovery of bioactive compounds: The Streptomyces paradigm No authors listed FEMS Microbiology Letters https://doi.org/10.1093/femsle/fny240		September 2018
Synthetic-Bioinformatic Natural Product Antibiotics with Diverse Modes of Action No authors listed Journal of the American Chemical Society https://doi.org/10.1021/jacs.0c04376		July 2020
A Semisynthetic Kanglemycin Shows In Vivo Efficacy against High-Burden Rifampicin Resistant Pathogens No authors listed ACS Infectious Diseases https://doi.org/10.1021/acsinfecdis.0c00223		August 2020
Aminoacyl-tRNA synthetases as therapeutic targets No authors listed Nature Reviews Drug Discovery https://doi.org/10.1038/s41573-019-0026-3		May 2019
Biosynthesis of Albomycin δ ₂ Provides a Template for Assembling Siderophore and Aminoacyl-tRNA Synthetase Inhibitor Conjugates No authors listed ACS Chemical Biology https://doi.org/10.1021/cb300173x		June 2012
A Branch Point of Streptomyces Sulfur Amino Acid Metabolism Controls the Production of Albomycin No authors listed Applied and Environmental Microbiology https://doi.org/10.1128/aem.02517-15		January 2016
Total synthesis and antimicrobial evaluation of natural albomycins against clinical pathogens No authors listed Nature Communications https://doi.org/10.1038/s41467-018-05821-1		September 2018
Identity of streptomycete producing antibiotic PA155A No authors listed Journal of Bacteriology https://doi.org/10.1128/jb.91.4.1663-.1966		April 1966
Indolmycin Inhibits Prokaryotic Tryptophanyl-tRNA Ligase No authors listed European Journal of Biochemistry https://doi.org/10.1111/j.1432-1033.1976.tb10758.x		September 1976
In vitro reconstitution of indolmycin biosynthesis reveals the molecular basis of oxazolinone assembly No authors listed Proceedings of the National Academy of Sciences https://doi.org/10.1073/pnas.1419964112		February 2015
Total synthesis of antibiotic indolmycin and its stereoisomers No authors listed Tetrahedron https://doi.org/10.1016/s0040-4020(01)96345-8		January 1968
Selective Inhibition of Bacterial Tryptophanyl-tRNA Synthetases by Indolmycin Is Mechanism-based No authors listed Journal of Biological Chemistry https://doi.org/10.1074/jbc.m115.690321		January 2016
A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase No authors listed Nature Chemical Biology https://doi.org/10.1038/nchembio.2420		July 2017
Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface No authors listed Scientific Reports https://doi.org/10.1038/s41598-017-09642-y		August 2017
The tryptophan biosynthetic pathway is essential for Mycobacterium tuberculosis to cause disease No authors listed Biochemical Society Transactions https://doi.org/10.1042/bst20200194		September 2020
A single amino acid substitution uncouples catalysis and allostery in an essential biosynthetic enzyme in Mycobacterium tuberculosis No authors listed Journal of Biological Chemistry https://doi.org/10.1074/jbc.ra120.012605		May 2020
Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs No authors listed Molecules https://doi.org/10.3390/molecules25061259		March 2020
Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing No authors listed Cell https://doi.org/10.1016/j.cell.2013.10.045		December 2013
A concise synthesis of (−)-indolmycin and (−)-5-methoxyindolmycin No authors listed Tetrahedron: Asymmetry https://doi.org/10.1016/j.tetasy.2008.07.013		August 2008
Where Do Recent Small Molecule Clinical Development Candidates Come From? No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.8b00675		June 2018
Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs: Miniperspective No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.8b00686		September 2018
Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis No authors listed mBio https://doi.org/10.1128/mBio.02133-16		January 2017
Crystal Structure of Tryptophanyl-tRNA Synthetase Complexed with Adenosine-5′ Tetraphosphate: Evidence for Distributed Use of Catalytic Binding Energy in Amino Acid Activation by Class I Aminoacyl-tRNA Synthetases No authors listed Journal of Molecular Biology https://doi.org/10.1016/j.jmb.2007.01.091		May 2007
A continuous kinetic assay for adenylation enzyme activity and inhibition No authors listed Analytical Biochemistry https://doi.org/10.1016/j.ab.2010.04.033		September 2010
Hydroxylamine-dependent reactions catalyzed by a lysyl-tRNA synthetase of Escherichia coli B No authors listed Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis https://doi.org/10.1016/0005-2787(73)90299-2		January 1973
Development of a Stereoselective Practical Synthetic Route to Indolmycin, a Candidate Anti-H. pylori Agent. No authors listed Chemical and Pharmaceutical Bulletin https://doi.org/10.1248/cpb.49.1604		January 2001
NH…O, OH…O, and CH…O hydrogen bonds in protein-ligand complexes: Strong and weak interactions in molecular recognition No authors listed Proteins: Structure, Function, and Bioinformatics https://doi.org/10.1002/prot.10567		November 2003
The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis No authors listed Frontiers in Microbiology https://doi.org/10.3389/fmicb.2015.00812		August 2015
Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application No authors listed mBio https://doi.org/10.1128/mBio.01586-16		May 2017
Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro No authors listed Journal of Antimicrobial Chemotherapy https://doi.org/10.1093/jac/dkl227		May 2006
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase No authors listed Antimicrobial Agents and Chemotherapy https://doi.org/10.1128/aac.01339-16		August 2016
Identification of Chemical Compounds That Inhibit the Function of Glutamyl-tRNA Synthetase from Pseudomonas aeruginosa No authors listed Journal of Biomolecular Screening https://doi.org/10.1177/1087057115591120		October 2015
Anti-staphylococcal activity of indolmycin, a potential topical agent for control of staphylococcal infections No authors listed Journal of Antimicrobial Chemotherapy https://doi.org/10.1093/jac/dkh352		July 2004
Targeting protein biotinylation enhances tuberculosis chemotherapy No authors listed Science Translational Medicine https://doi.org/10.1126/scitranslmed.aal1803		April 2018
Structure and inhibition of subunit I of the anthranilate synthase complex of Mycobacterium tuberculosis and expression of the active complex No authors listed Acta Crystallographica Section D Biological Crystallography https://doi.org/10.1107/s1399004715017216		October 2015
Evolving the naturally compromised chorismate mutase from Mycobacterium tuberculosis to top performance No authors listed Journal of Biological Chemistry https://doi.org/10.1074/jbc.RA120.014924		December 2020
Mycobacterium tuberculosis chorismate mutase: A potential target for TB No authors listed Bioorganic & Medicinal Chemistry https://doi.org/10.1016/j.bmc.2017.02.001		March 2017
Rapid and spontaneous loss of phthiocerol dimycocerosate (PDIM) from Mycobacterium tuberculosis grown in vitro: implications for virulence studies No authors listed Microbiology https://doi.org/10.1099/mic.0.029199-0		November 2009
High Persister Mutants in Mycobacterium tuberculosis No authors listed PLOS ONE https://doi.org/10.1371/journal.pone.0155127		May 2016
Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes No authors listed Nature Communications https://doi.org/10.1038/s41467-019-12074-z		September 2019
Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1 No authors listed Frontiers in Cellular and Infection Microbiology https://doi.org/10.3389/fcimb.2017.00151		May 2017
Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance No authors listed Proceedings of the National Academy of Sciences https://doi.org/10.1073/pnas.1907631116		September 2019
Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy No authors listed mBio https://doi.org/10.1128/mbio.00663-19		August 2019
Energy Metabolism and Drug Efflux in Mycobacterium tuberculosis No authors listed Antimicrobial Agents and Chemotherapy https://doi.org/10.1128/aac.02293-13		March 2014
The Structure of Indolmycin No authors listed Journal of the American Chemical Society https://doi.org/10.1021/ja01483a056		November 1961
Thiazolinone analogs of indolmycin with antiviral and antibacterial activity No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/jm00199a015		January 1978
Directed biosynthesis of new indolmycins. No authors listed The Journal of Antibiotics https://doi.org/10.7164/antibiotics.34.551		January 1981
New total synthesis of (.+-.)-indolmycin No authors listed The Journal of Organic Chemistry https://doi.org/10.1021/jo00375a030		December 1986
Structure-activity dependency of new bacterial tryptophanyl tRNA synthetase inhibitors No authors listed Bioorganic & Medicinal Chemistry Letters https://doi.org/10.1016/0960-894x(96)00237-5		June 1996
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis No authors listed European Journal of Medicinal Chemistry https://doi.org/10.1016/j.ejmech.2021.113843		December 2021
Resistance of Mycobacterium tuberculosis to indole 4-carboxamides occurs through alterations in drug metabolism and tryptophan biosynthesis No authors listed Cell Chemical Biology https://doi.org/10.1016/j.chembiol.2021.02.023		August 2021
Mechanism of Fluorinated Anthranilate-Induced Growth Inhibition in Mycobacterium tuberculosis No authors listed ACS Infectious Diseases https://doi.org/10.1021/acsinfecdis.8b00092		November 2018
Hit and lead criteria in drug discovery for infectious diseases of the developing world No authors listed Nature Reviews Drug Discovery https://doi.org/10.1038/nrd4683		October 2015
NTM drug discovery: status, gaps and the way forward No authors listed Drug Discovery Today https://doi.org/10.1016/j.drudis.2018.04.001		August 2018
Identification of Thiotetronic Acid Antibiotic Biosynthetic Pathways by Target-directed Genome Mining No authors listed ACS Chemical Biology https://doi.org/10.1021/acschembio.5b00658		October 2015
Resistance-Guided Discovery of Elfamycin Antibiotic Producers with Antigonococcal Activity No authors listed ACS Infectious Diseases https://doi.org/10.1021/acsinfecdis.0c00467		November 2020
Antibiotic GE2270 A: A novel inhibitor of bacterial protein synthesis. I. Isolation and characterization. No authors listed The Journal of Antibiotics https://doi.org/10.7164/antibiotics.44.693		January 1991
Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections No authors listed Antimicrobial Agents and Chemotherapy https://doi.org/10.1128/aac.04251-14		December 2014
Rediscovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis No authors listed Journal of Biological Chemistry https://doi.org/10.1016/j.jbc.2021.100257		January 2021

Similar Records

Crystallization and Stress Relaxation in Highly Stretched Samples of Natural Rubber and its Synthetic Analogue

Journal Article · 2006 · Macromolecules · OSTI ID:959893

Tosaka, M; Kawakami, D; Senoo, K; +3 more

Surface reactions of synthetic, end-member analogues of monazite, xenotime and rhabdophane, and evolution of natural waters

Journal Article · 1988 · Geochimica et Cosmochimica Acta; (USA) · OSTI ID:5254277

Jonasson, R G; Bancroft, G M; Boatner, L A

Photophysical Characterization of the Naturally Occurring Dioxobacteriochlorin Tolyporphin A and Synthetic Oxobacteriochlorin Analogues

Journal Article · 2017 · Photochemistry and Photobiology · OSTI ID:1388047

Hood, Don; Niedzwiedzki, Dariusz M.; Zhang, Ran; +7 more

Investigate Natural Product Indolmycin and the Synthetically Improved Analogue Toward Antimycobacter

Citation Formats

References (65)

Similar Records

Related Subjects